Front Row Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.4K | Hold |
300
| – | – | ﹤0.01% | 361 |
|
|
2026
Q1 | $18.8K | Hold |
300
| – | – | 0.01% | 321 |
|
|
2025
Q4 | $28.6K | Hold |
300
| – | – | 0.01% | 274 |
|
|
2025
Q3 | $29.3K | Hold |
300
| – | – | 0.01% | 261 |
|
|
2025
Q2 | $32.2K | Hold |
300
| – | – | 0.01% | 243 |
|
|
2025
Q1 | $30.3K | Hold |
300
| – | – | 0.01% | 259 |
|
|
2024
Q4 | $26.8K | Hold |
300
| – | – | 0.01% | 264 |
|
|
2024
Q3 | $25.1K | Hold |
300
| – | – | 0.01% | 275 |
|
|
2024
Q2 | $23.1K | Hold |
300
| – | – | 0.01% | 389 |
|
|
2024
Q1 | $20.5K | Hold |
300
| – | – | 0.01% | 412 |
|
|
2023
Q4 | $17.3K | Hold |
300
| – | – | 0.01% | 272 |
|
|
2023
Q3 | $15.8K | Hold |
300
| – | – | 0.01% | 428 |
|
|
2023
Q2 | $16K | Hold |
300
| – | – | 0.01% | 422 |
|
|
2023
Q1 | $15K | Hold |
300
| – | – | 0.01% | 429 |
|
|
2022
Q4 | $14K | Hold |
300
| – | – | 0.01% | 428 |
|
|
2022
Q3 | $12K | Hold |
300
| – | – | 0.01% | 458 |
|
|
2022
Q2 | $11K | Hold |
300
| – | – | 0.01% | 489 |
|
|
2022
Q1 | $13K | Hold |
300
| – | – | 0.01% | 494 |
|
|
2021
Q4 | $13K | Hold |
300
| – | – | ﹤0.01% | 508 |
|
|
2021
Q3 | $13K | Hold |
300
| – | – | 0.01% | 499 |
|
|
2021
Q2 | $13K | Hold |
300
| – | – | 0.01% | 501 |
|
|
2021
Q1 | $12K | Hold |
300
| – | – | 0.01% | 504 |
|
|
2020
Q4 | $11K | Hold |
300
| – | – | 0.01% | 490 |
|
|
2020
Q3 | $10K | Hold |
300
| – | – | 0.01% | 504 |
|
|
2020
Q2 | $11K | Hold |
300
| – | – | 0.01% | 443 |
|
|
2020
Q1 | $11K | Hold |
300
| – | – | 0.01% | 444 |
|
|
2019
Q4 | $14K | Hold |
300
| – | – | 0.01% | 387 |
|
|
2019
Q3 | $12K | Hold |
300
| – | – | 0.01% | 404 |
|
|
2019
Q2 | $13K | Hold |
300
| – | – | 0.01% | 387 |
|
|
2019
Q1 | $12K | Hold |
300
| – | – | 0.01% | 405 |
|
|
2018
Q4 | $11K | Hold |
300
| – | – | 0.01% | 383 |
|
|
2018
Q3 | $11K | Hold |
300
| – | – | 0.01% | 406 |
|
|
2018
Q2 | $10K | Hold |
300
| – | – | 0.01% | 452 |
|
|
2018
Q1 | $8K | Hold |
300
| – | – | 0.01% | 466 |
|
|
2017
Q4 | $7K | Buy |
+300
| New | +$8.27K | 0.01% | 481 |
|
Other funds holding BSX
Front Row Advisors's BSX Position: Q2 2026 in Review
Front Row Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 300 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #361.
Front Row Advisors first reported a position in BSX in Q4 2017 and has held it in 35 quarters since. The position peaked at $32.2K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Front Row Advisors held 300 shares of Boston Scientific worth $15.4K as of Q2 2026.
- Front Row Advisors left its Boston Scientific share count unchanged in Q2 2026.
- Boston Scientific made up ﹤0.01% of Front Row Advisors's portfolio in Q2 2026, its #361 holding.
- Front Row Advisors first reported a position in Boston Scientific in Q4 2017 and has held it in 35 quarters since.
- Front Row Advisors's Boston Scientific position peaked at $32.2K in Q2 2025.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.